刘丹, 白雪, 刘桂敏, 樊晓蕾, 唐田, 于淑俊, 刘柘君, 江波, 刘振权. 前列腺增生症发病机制的研究进展[J]. 实用临床医药杂志, 2021, 25(5): 112-117. DOI: 10.7619/jcmp.20210021
引用本文: 刘丹, 白雪, 刘桂敏, 樊晓蕾, 唐田, 于淑俊, 刘柘君, 江波, 刘振权. 前列腺增生症发病机制的研究进展[J]. 实用临床医药杂志, 2021, 25(5): 112-117. DOI: 10.7619/jcmp.20210021
LIU Dan, BAI Xue, LIU Guimin, FAN Xiaolei, TANG Tian, YU Shujun, LIU Zhejun, JIANG Bo, LIU Zhenquan. Research progress on pathogenesis of benign prostatic hyperplasia[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 112-117. DOI: 10.7619/jcmp.20210021
Citation: LIU Dan, BAI Xue, LIU Guimin, FAN Xiaolei, TANG Tian, YU Shujun, LIU Zhejun, JIANG Bo, LIU Zhenquan. Research progress on pathogenesis of benign prostatic hyperplasia[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 112-117. DOI: 10.7619/jcmp.20210021

前列腺增生症发病机制的研究进展

Research progress on pathogenesis of benign prostatic hyperplasia

  • 摘要: 前列腺增生症(BPH)好发于中老年男性,是一类与下尿路症状相关的慢性疾病,临床治疗效果不佳,易复发,严重影响患者的生活质量。近几年国内外广泛开展了针对BPH的临床研究,但关于BPH发病机制的相关综述却较少见。本文检索并总结国内外相关文献,从性激素、多肽生长因子、炎症信号传导、细胞凋亡、氧化应激、平滑肌6个方面将BPH发病机制的研究进展综述如下,旨在为BPH的临床用药和新药开发提供理论支撑。

     

    Abstract: Benign prostatic hyperplasia (BPH) mainly occurs in middle-aged and elderly men, and it is a chronic disease related to lower urinary tract symptoms. Due to poor clinical treatment effect and easy recurrence, it has seriously affected the quality of life of patients. In recent years, clinical researches on BPH have been widely carried out at home and abroad, but the related reviews on the pathogenesis of BPH were rare. In this paper, the related literatures at home and abroad were searched and summarized, and the research progress of pathogenesis of BPH was summarized from six aspects: sex hormone, polypeptide growth factor, inflammatory signal transduction, apoptosis, oxidative stress and smooth muscle, hoping to provide theoretical support for clinical medication and new drug development of BPH.

     

/

返回文章
返回